Back | Next |
home / stock / tlsa / tlsa message board
Subject | By | Source | When |
---|---|---|---|
Price gaining | Crusader | investorshub | 10/03/2023 1:48:52 AM |
$TLSA short squeeze | Lanceroni | investorshub | 10/03/2023 12:14:57 AM |
Price trading | Count Crypto | investorshub | 10/02/2023 11:51:46 PM |
MomentumIts gaining last up | mfayman | investorshub | 10/02/2023 11:49:48 PM |
$TLSA Price trading | Count Crypto | investorshub | 10/02/2023 8:48:43 PM |
MomentumIts gaining | Count Crypto | investorshub | 10/02/2023 6:52:44 PM |
Found an interesting article | The Night Stalker | investorshub | 10/02/2023 5:47:10 PM |
$TLSA Good read | Anita Dump | investorshub | 10/02/2023 4:57:45 PM |
Good read | Anita Dump | investorshub | 10/02/2023 12:14:51 PM |
Have a look at this | Count Crypto | investorshub | 10/02/2023 11:15:09 AM |
$TLSA we got news | elmasry | investorshub | 10/02/2023 10:42:45 AM |
bulls and bears | TREND1 | investorshub | 10/02/2023 10:37:43 AM |
Good read | Anita Dump | investorshub | 10/02/2023 10:27:37 AM |
$TLSA Price now | Count Crypto | investorshub | 10/02/2023 10:00:25 AM |
Price now | mfayman | investorshub | 10/02/2023 9:48:13 AM |
Found an interesting article | Count Crypto | investorshub | 10/02/2023 7:31:18 AM |
Price now | TREND1 | investorshub | 10/02/2023 7:01:44 AM |
Good news recently, we should start to see this one move | nickwill69 | investorshub | 10/02/2023 6:47:49 AM |
short squeeze | Crusader | investorshub | 10/02/2023 6:06:31 AM |
short data if anyone is interested | mfayman | investorshub | 10/02/2023 4:25:56 AM |
News, Short Squeeze, Breakout and More Instantly...
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Tiziana Life Sciences plc Website:
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
--News Direct-- Tiziana Life Sciences Ltd (NASDAQ:TLSA) chairman and CEO Gabriele Cerrone joined Proactive's Stephen Gunnion with more details of the company's recent advancements and news. Tiziana Life Sciences is developing a fully human CD3 monoclonal antibody, delivered intranasally, ...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the U.S. Food and Dru...